Mental Health

A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Patients With a History of Being Poorly Compliant With Taking Their Medication
Mental Health 01 Jan 2013

A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Patients With a History of Being Poorly Compliant With Taking Their Medication

The purpose of this study is to evaluate risperidone long-acting injection (an antipsychotic medication) versus oral antipsychotics in schizophrenia patients with a history of being poorly compliant with taking their medication. Official Title Pragmatic Randomized Trial of ‘Risperdal CONSTA’ (Risperidone) Versus Oral Atypical Antipsychotics in Poorly Adherent Subjects With Schizophrenia…
Mental Health 01 Jan 2013

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer’s Disease

The purpose of the study is to determine the safety, tolerability, and efficacy of 3 doses of lecozotan in combination with a cholinesterase inhibitor in patients with mild to moderate Alzheimer’s disease (AD). Official Title A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Safety, Tolerability, and Efficacy Study of 3 Doses of…
Mental Health 01 Jan 2013

Prospective Research in Memory Clinics (PRIME), a Disease Registry for Current Management of Treatment and Outcome in Patients With Dementia (or Alzheimer’s).

The purpose of the PRIME (Prospective Research in Memory Clinics) Study is to examine the current management and outcomes of patients with dementia. Approximately 4500 subjects will be enrolled in this disease registry across 12 sites in Australia. Clinical, treatment, health status and economic data will be acquired over 3…
Treatment of Comorbid Depression and Substance Abuse in Young People
Mental Health 01 Jan 2013

Treatment of Comorbid Depression and Substance Abuse in Young People

This study aims to treat young people with an adjunctive integrated Cognitive Behaviour Therapy (CBT) intervention and to examine the acceptability of this treatment approach within this population. The study will also include a pilot placebo-controlled trial of sertraline for those young people who fail to or only partially respond…
Trial for the Treatment of Alcohol Dependence
Mental Health 01 Jan 2013

Trial for the Treatment of Alcohol Dependence

The purpose of this study is to compare the effectiveness of two anti-craving medications, naltrexone versus acamprosate, in the treatment of alcohol dependence. Official Title The Role of Pharmacotherapy in Prevention of Relapse in Alcohol Dependence Conditions Alcoholism Study Type Interventional Study Design Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment,…
An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder
Mental Health 01 Jan 2013

An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder

The precursor study (SCA101469) was an open-label, prospective multicentre study in adult subjects diagnosed with bipolar disorder consisting of 36 weeks treatment with lamotrigine. The current study is to provide 12 months post study access to open-label lamotrigine for participants of the SCA101469 study. Official Title An Open-Label Extension Study…
Transcranial Magnetic Stimulation for Bipolar Depression
Mental Health 01 Jan 2013

Transcranial Magnetic Stimulation for Bipolar Depression

This is a study to assess the effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a treatment for depressed adults with bipolar disorder. Official Title A Comparison of Left vs. Right Prefrontal Cortex Transcranial Magnetic Stimulation as a Treatment for Bipolar Depression Conditions Bipolar Depression Study Type Interventional Study Design…
Children's health 01 Jan 2013

Long-Term, Open Label Atomoxetine Study on Attention Deficit Hyperactivity Disorder

To learn about the safety and any side effects of atomoxetine when given to children and adolescents for about 5 years (long-term) and to learn whether atomoxetine can help children and adolescents with ADHD who take the drug for about 5 years (long-term). Official Title Long-Term, Open Label Safety Study…
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
Mental Health 01 Jan 2013

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

This is a clinical trial assessing duloxetine and comparator to placebo in patients who have generalized anxiety disorder. Official Title A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder Conditions Generalised Anxiety Disorder Study Type Interventional Study Design Treatment, Randomized, Double-Blind, Placebo…